ACC Cardio-oncology Course Aims to Advance Cardiovascular Care of Cancer Patients, Survivors

DOORwaY-90 Study for SIR-Spheres® Therapy as 1st-line Treatment for Hepatocellular Carcinoma Enrolls First Patient

The study will assess the duration of response (DoR) and objective response rate (ORR) of SIR-Spheres. It is being led by co-principal investigators Cheenu Kappadath, PhD and Dr. Armeen Mahvash.

Global Surgical Lasers Market to Reach $10.1 Billion by 2027

1 Billion by 2027, growing at a CAGR of 9.7% over the analysis period 2020-2027. Solid-State Laser Systems, one of the segments analyzed in the report, is projected to record a 9.2% CAGR and reach US$3.9 Billion by the end of the analysis period.

Carestream Health Advances X-ray Image Quality with Smart Noise Cancellation

SNC has received FDA 510(k) Clearance and is available as an optional feature with Carestream’s ImageView Software powered by Eclipse—the intelligent image-processing engine behind the company’s innovative imaging software—on DRX-Evolution and DRX-Evolution Plus systems.

January 21, 2021

ACC Cardio-oncology Course: The American College of Cardiology will host the annual Advancing the Cardiovascular Care of the Oncology Patient Virtual course with live sessions on Feb. 5-6, 2021, and on demand content. The course will feature cardiology and oncology experts providing clinically relevant, best practice strategies for a multidisciplinary team regarding the assessment, diagnosis and management of cardiovascular concerns for cancer patients, as well as those requiring survivorship care.

ACC Cardio-oncology Course co-directors Ana Barac, MD, Ph.D., FACC, and Bonnie Ky, MD, MSCE, FACC, have invited respected experts in the field to create a course covering relevant and required content for both the novice and advanced practitioner. The conference aims to provide participants with the tools needed to improve patient care in their everyday practice in this rapidly evolving field through describing the evolving advances in immunotherapy and the associated cardiotoxicity; defining cardiovascular complications in cancer patients that are specific to coronary disease, vascular disease and bleeding; applying evidence-based strategies for short- and long-term surveillance; and establishing interprofessional cardio-oncology care teams and a framework to improve overall cardiovascular care of cancer patients and survivors.

Sessions Include:

  • Immune Therapy and Cardiovascular Risk
  • Adult and Pediatric Cancer Survivorship: Management of Modifiable Cardiovascular Risk Factors
  • All About Amyloidosis

The course will also feature on-demand content available beginning on Monday, January 25, 2021.

Posters

The following abstracts are a selection of the posters being presented. All ACC Advancing the Cardiovascular Care of the Oncology Patient abstracts are embargoed until Monday, Jan. 25, 2021 at 8 a.m. ET.

  • Cardiovascular Outcomes Associated with Chemotherapy and Targeted Therapies in Adolescent and Young Adult Cancer Survivors
  • Cardiovascular Risk Factors and Comorbidities in Male Breast Cancer Patients (press release available)
  • Risk of Cardiotoxicity with Dual Human Epidermal Receptor (HER2) Targeted Therapies in Breast Cancer
  • The Association of Physical Activity, Cardiac and Patient-Reported Outcomes in HER2+ Breast Cancer Survivors During Therapy
spot_img

DON'T MISS

Subscribe to Medical Device News Magazine here.

Related Articles